Leading the Way in Life Science Technologies

GEN Exclusives

More »
Readers Comments Back to Item »

The Big Idea for 2009 as Discussed at J.P. Morgan

1 Readers' Comments

Posted by: Thanks for your research

01/17/2009

Hello Rod ,

I've long been a shareholder of a Canadian biotech ( Spectral Diagnostics) their real interest is in the Sepsis field . I was curious , was Sepsis management ( 17B / year problem ) addressed much at the conference . We have the only FDA approved test for endotoxin measurement , and are on the verge of submitting a FDA request for a Japanese therapeutic coupled with our test ( EAA ) The stock has been on a 5 year slide , would love some feedback .

Thanks so much ,
Paul Djonovich

  • Click here to Login or to Register for free.

    You will be taken back to your selected item after Login/Registration.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »